基础医学与临床2017，Vol.37Issue(6)：884-888,5.
卡培他滨联合化疗双周方案研究进展
Research progress of capecitabine combined chemotherapy with biweekly scheme
马守东 1孙国贵 1张弘纲2
作者信息
- 1. 唐山市人民医院 肿瘤内科, 河北 唐山 063000
- 2. 中国医学科学院 肿瘤医院 肿瘤内科, 北京 100021
- 折叠
摘要
Abstract
As an oral chemotherapy drug, capecitabine is safe, effective and easy to use, has been widely used in the treatment of esophageal cancer, gastric cancer, colorectal cancer, breast cancer, ovarian cancer and other solid tumor.The chemotherapy scheme is mainly for 3 weeks, each cycle of capecitabine for 14 days, and 7 days off.As a modification to conventional chemotherapy, the biweekly scheme with capecitabine showed low toxicity and well tolerated by patients, short hospitalization time and other characteristics, it is worth of application in clinical.关键词
卡培他滨/化疗/双周方案Key words
capecitabine/chemotherapy/biweekly scheme分类
医药卫生引用本文复制引用
马守东,孙国贵,张弘纲..卡培他滨联合化疗双周方案研究进展[J].基础医学与临床,2017,37(6):884-888,5.
